Protective efficacy of a live attenuated vaccine against argentine hemorrhagic fever

Journal of Infectious Diseases

Volumn 177, Issue 2, 1998, Pages 277-283

  Maiztegui, Julio I ^d   McKee Jr , Kelly T ^a   Oro, Julio G Barrera ^d   Harrison, Lee H ^b   Gib, Paul H ^d   Feuillade, Maria R ^d   Enria, Delia A ^d   Briggile, Ana M ^d   Levis, Silvana C ^d   Ambrosio, Ana M ^d   Halsey, Neal A ^d   Peters, Clarence J ^c  

^a WOMACK ARMY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Centers for Disease Control ^*

Author keywords

[No Author keywords available]

Indexed keywords

JUNIN VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADOLESCENT; ADULT; ANTIBODY TITER; ARGENTINA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEVER; HEADACHE; HEMORRHAGIC FEVER; HUMAN; HUMAN EXPERIMENT; JUNIN VIRUS; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; VIRUS INFECTION;

EID: 6844257535     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514211     Document Type: Article

References (19)

1. Peters CJ, Johnson KM. Lymphocytic choriomeningitis virus, Lassa virus, and other arenaviruses. In: Mandel GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:1835-45.
2. Arribalzaga RA. Una nueva enfermedad epidemica a germen desconocido: hipertermia nefrotoxica, leucopenia, y enatemica. Dia Medico 1955;27:1204-10.
3. Maiztegui JI. Clinical and epidemiological patterns of Argentine hemorrhagic fever. Bull WHO 1975;52:567-75.
4. Maiztegui JI, Fernandez NJ, de Damilano AJ. Efficacy of immune plasma treatment of Argentine hemorrhagic fever and association between treatment and a late neurologic syndrome. Lancet 1979;2:1216-7.
5. Mills JN, Ellis BA, McKee KT Jr, et al. Junin virus activity in rodents from endemic and nonendemic loci in central Argentina. Am J Trop Med Hyg 1991;44:589-97.
6. Mills JN, Ellis BA, McKee KT Jr, Calderon GE, Maiztegui JI. A longitudinal study of Junin virus activity in the rodent reservoir of Argentine hemorrhagic fever. Am J Trop Med Hyg 1992;47:749-63.
7. Barrera Oro JG, McKee KT Jr. Toward a vaccine against Argentine hemorrhagic fever. Bull Pan Am Health Organ 1991;25:118-26.
8. Barrera Oro J, Eddy G. Characteristics of candidate live attenuated Junin virus vaccine [abstract S4-10]. In: Program and abstracts of the Fourth International Conference on Comparative Virology (Banff, Canada), 1982.
9. McKee KT Jr, Barrera Oro JG, Kuehne AI, Spisso JA, Mahlandt BG. Candid no. 1 Argentine hemorrhagic fever vaccine protects against lethal Junin virus challenge in rhesus macaques. Intervirology 1992;34:154-63.
10. McKee KT Jr, Barrera Oro JG, Kuehne AI, Spisso JA, Mahlandt BG. Safety and immunogenicity of a live-attenuated Junin (Argentine hemorrhagic fever) vaccine in rhesus macaques. Am J Trop Med Hyg 1993;48:403-11.
11. Harrison LH, Halsey NA, McKee KT, et al. Clinical case definition for the arenavirus infection Argentine hemorrhagic fever [abstract LM85]. In: Program and abstracts of the 35th Interscience Conference on Anti-microbial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1995.
12. Whalen KH. Demonstration of inapparent heterogeneity in a population of an animal virus by single-burst analysis. Virology 1963;20:230-4.
13. MacDonald C, McKee K, Peters C, Feinsod F, Cosgriff T, Barrera Oro J. Initial clinical assessment of humans inoculated with a live-attenuated Junin virus vaccine [abstract R3.27]. In: Program and abstracts of the VII International Congress of Virology (Edmonton, Canada), 1987.
14. MacDonald C, McKee K, Meegan J, et al. Initial evaluation in humans of a live-attenuated vaccine against Argentine hemorrhagic fever. In: Proceedings of the XVI Army Science Conference (Hampton, Virginia), US Army, 1988.
15. Maiztegui J, Levis S, Enria D, et al. Inocuidad e inmunogenicidad en seres humanos de la cepa Candid l de virus Junin [abstract]. Medicina (Buenos Aires) 1988;6:660.
16. Maiztegui JI, McKee KT Jr. Inoculation of human volunteers with a vaccine against Argentine hemorrhagic fever [abstract S4]. In: Program and abstracts of the Sixth International Conference on Comparative and Applied Virology (Banff, Canada), 1989.
17. Barrera Oro JG, McKee KT Jr, Spisso J, Mahlandt BG, Maiztegui JI. A refined complement-enhanced neutralization test for detecting antibodies to Junin virus. J Virol Methods 1990;29:71-80.
18. Ambrosio AM, Enria DA, Maiztegui JI. Junin virus isolation from lymphomononuclear cells of patients with Argentine hemorrhagic fever. Intervirology 1986;25:97-102.
19. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research: Principles and quantitative methods. Belmont, CA: Lifetime Learning Publications, 1982.